This HTML5 document contains 49 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
dctermshttp://purl.org/dc/terms/
n17http://linked.opendata.cz/resource/domain/vavai/riv/tvurce/
n12http://linked.opendata.cz/resource/domain/vavai/subjekt/
n6http://linked.opendata.cz/resource/domain/vavai/vysledek/RIV%2F00064203%3A_____%2F11%3A7063%21RIV12-MZ0-00064203/
n11http://linked.opendata.cz/ontology/domain/vavai/
shttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
n3http://linked.opendata.cz/ontology/domain/vavai/riv/
n2http://linked.opendata.cz/resource/domain/vavai/vysledek/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n7http://linked.opendata.cz/ontology/domain/vavai/riv/klicoveSlovo/
n15http://linked.opendata.cz/ontology/domain/vavai/riv/duvernostUdaju/
xsdhhttp://www.w3.org/2001/XMLSchema#
n10http://linked.opendata.cz/ontology/domain/vavai/riv/jazykVysledku/
n4http://linked.opendata.cz/ontology/domain/vavai/riv/aktivita/
n18http://linked.opendata.cz/ontology/domain/vavai/riv/druhVysledku/
n16http://linked.opendata.cz/ontology/domain/vavai/riv/obor/
n13http://reference.data.gov.uk/id/gregorian-year/

Statements

Subject Item
n2:RIV%2F00064203%3A_____%2F11%3A7063%21RIV12-MZ0-00064203
rdf:type
n11:Vysledek skos:Concept
rdfs:seeAlso
http://www.ncbi.nlm.nih.gov/pubmed/21658647
dcterms:description
Pulmonary exacerbations represent a key outcome variable in clinical trials of cystic fibrosis (CF). As there is variation in the trigger for use of intravenous antibiotics compared to the use of oral antibiotics or new nebulised therapy for treatment of exacerbations, the consensus view is that use of intravenous antibiotics cannot be regarded as the key defining character for an exacerbation on its own. The consensus view is that the clinical need for additional treatment as indicated by a recent change in clinical parameters provides the best definition of an exacerbation. Which parameters to include as well as the problems associated with the use of scoring systems and symptom clusters are being discussed. (C) 2011 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved. Pulmonary exacerbations represent a key outcome variable in clinical trials of cystic fibrosis (CF). As there is variation in the trigger for use of intravenous antibiotics compared to the use of oral antibiotics or new nebulised therapy for treatment of exacerbations, the consensus view is that use of intravenous antibiotics cannot be regarded as the key defining character for an exacerbation on its own. The consensus view is that the clinical need for additional treatment as indicated by a recent change in clinical parameters provides the best definition of an exacerbation. Which parameters to include as well as the problems associated with the use of scoring systems and symptom clusters are being discussed. (C) 2011 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.
dcterms:title
Pulmonary exacerbation: Towards a definition for use in clinical trials. Report from the EuroCareCF Working Group on outcome parameters in clinical trials Pulmonary exacerbation: Towards a definition for use in clinical trials. Report from the EuroCareCF Working Group on outcome parameters in clinical trials
skos:prefLabel
Pulmonary exacerbation: Towards a definition for use in clinical trials. Report from the EuroCareCF Working Group on outcome parameters in clinical trials Pulmonary exacerbation: Towards a definition for use in clinical trials. Report from the EuroCareCF Working Group on outcome parameters in clinical trials
skos:notation
RIV/00064203:_____/11:7063!RIV12-MZ0-00064203
n11:predkladatel
n12:ico%3A00064203
n3:aktivita
n4:I
n3:aktivity
I
n3:cisloPeriodika
Suppl. 2
n3:dodaniDat
n13:2012
n3:domaciTvurceVysledku
n17:5147972
n3:druhVysledku
n18:J
n3:duvernostUdaju
n15:S
n3:entitaPredkladatele
n6:predkladatel
n3:idSjednocenehoVysledku
225251
n3:idVysledku
RIV/00064203:_____/11:7063
n3:jazykVysledku
n10:eng
n3:klicovaSlova
Pulmonary exacerbation; Cystic fibrosis; Outcome parameters; Definition; Consensus; cystic-fibrosis
n3:klicoveSlovo
n7:Pulmonary%20exacerbation n7:cystic-fibrosis n7:Outcome%20parameters n7:Definition n7:Consensus n7:Cystic%20fibrosis
n3:kodStatuVydavatele
NL - Nizozemsko
n3:kontrolniKodProRIV
[2BD16C488932]
n3:nazevZdroje
Journal of Cystic Fibrosis
n3:obor
n16:FC
n3:pocetDomacichTvurcuVysledku
1
n3:pocetTvurcuVysledku
9
n3:rokUplatneniVysledku
n13:2011
n3:svazekPeriodika
10
n3:tvurceVysledku
Conway, S. Bilton, D. Hjelte, L. Tummler, B. Canny, G. Vávrová, Věra Proesmans, M. Dumcius, S. De Boeck, K.
n3:wos
000292068000012
s:issn
1569-1993
s:numberOfPages
3